Biofrontera Inc (BFRI) concluded trading on Thursday at a closing price of $1.23, with 132.34 million shares of worth about $162.78 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -31.28% during that period and on October 31, 2024 the price saw a gain of about 31.71%. Currently the company’s common shares owned by public are about 5.54M shares, out of which, 3.27M shares are available for trading.
Stock saw a price change of 26.80% in past 5 days and over the past one month there was a price change of 14.95%. Year-to-date (YTD), BFRI shares are showing a performance of -55.60% which decreased to -73.83% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.61 but also hit the highest price of $5.28 during that period. The average intraday trading volume for Biofrontera Inc shares is 405.62K. The stock is currently trading 39.12% above its 20-day simple moving average (SMA20), while that difference is up 14.76% for SMA50 and it goes to 3.11% higher than SMA200.
Biofrontera Inc (NASDAQ: BFRI) currently have 5.54M outstanding shares and institutions hold larger chunk of about 22.26% of that.
The stock has a current market capitalization of $6.82M and its 3Y-monthly beta is at 0.51. It has posted earnings per share of -$5.92 in the same period. It has Quick Ratio of 1.46 while making debt-to-equity ratio of 0.13. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for BFRI, volatility over the week remained 44.22% while standing at 22.26% over the month.
Stock’s fiscal year EPS is expected to rise by 75.31% while it is estimated to increase by 73.25% in next year.
